LOVISCOL Carbocisteine 100mg / 5mL Syrup 120mL
NONRXDRUG-DRHR-789-120
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
Capsule: This product is used as adjunctive mucolytic therapy for respiratory tract disorders characterized by excessive or viscous mucous, such as acute and chronic bronchitis, bronchiectasis, asthmatic bronchitis and emphysema. Adjunctive therapy in otorhinolaryngology for otitis, sinusitis, nasopharyngitis, tubal otorrhea and for reducing hypersecretion prior to surgery.
Pediatric Syrup/Infant Drops: Carbocisteine (Loviscol) is used as adjunctive therapy for chronic disorders of the respiratory tract associated with excessive or viscous mucus, such as chronic bronchitis, chronic obstructive pulmonary disease and otitis media with effusion including glue ear.
Pediatric Syrup/Infant Drops: Carbocisteine (Loviscol) is used as adjunctive therapy for chronic disorders of the respiratory tract associated with excessive or viscous mucus, such as chronic bronchitis, chronic obstructive pulmonary disease and otitis media with effusion including glue ear.
Dosage/Direction for Use
Capsule: One capsule every 8 hours or 3 times a day or as prescribed by a physician.
Pediatric Syrup: See table.
Pediatric Syrup: See table.
Infant Drops: 13-24 months: 1.2 mL every 6 hours or as prescribed by physician.
Overdosage
Reports of overdosage with Carbocisteine do not provide consistent data regarding the signs and symptoms of overdose.
There is no known antidote for overdosage. Treatment is symptomatic and supportive. If vomiting has not occurred it should be induced by conventional means or gastric lavage may be instituted. In case of accidental overdose or at the first sign of any adverse reaction, discontinue use and seek professional assistance immediately.
There is no known antidote for overdosage. Treatment is symptomatic and supportive. If vomiting has not occurred it should be induced by conventional means or gastric lavage may be instituted. In case of accidental overdose or at the first sign of any adverse reaction, discontinue use and seek professional assistance immediately.
Administration
Should be taken with food.
Contraindications
These products are contraindicated in patients with active peptic ulcer and in cases of known hypersensitivity to Carbocisteine or any of the components of the product.
Special Precautions
Taking of multiple antitussive agents with Carbocisteine is not recommended.
Patients with a history of peptic ulceration should be examined prior to carbocisteine administration to exclude the presence of an active ulcer.
Do not exceed recommended daily dose.
Patients with a history of peptic ulceration should be examined prior to carbocisteine administration to exclude the presence of an active ulcer.
Do not exceed recommended daily dose.
Use In Pregnancy & Lactation
Use in Pregnancy: The safety of Carbocisteine for use during pregnancy has not been established. It should not be used in pregnant women unless, in the judgment of the physician, the expected benefits substantially outweigh the potential risk to the fetus.
Adverse Reactions
Capsule: Endocrine disorders: Transient hypothyroidism in a patient with compromised thyroid function.
Nervous System disorders: Headache Gastrointestinal disorders: mild gastrointestinal symptoms such as nausea, diarrhea, gastric discomfort which often subside on lowering the dose or discontinuing the treatment, gastrointestinal bleeding has also been reported.
Skin and Subcutaneous Tissue disorders: Allergic reactions including occasional skin rash and urticaria, angioedema.
Pediatric Syrup/Infant Drops: Nausea, diarrhea, gastric discomfort, gastrointestinal bleeding, and skin rash have occasionally occurred.
Nervous System disorders: Headache Gastrointestinal disorders: mild gastrointestinal symptoms such as nausea, diarrhea, gastric discomfort which often subside on lowering the dose or discontinuing the treatment, gastrointestinal bleeding has also been reported.
Skin and Subcutaneous Tissue disorders: Allergic reactions including occasional skin rash and urticaria, angioedema.
Pediatric Syrup/Infant Drops: Nausea, diarrhea, gastric discomfort, gastrointestinal bleeding, and skin rash have occasionally occurred.
Drug Interactions
Dilution with syrups containing pholcodine will cause precipitation.
The use of concomitant antitussive agents is not recommended.
In human studies, no interaction has been found between carbocisteine and antibiotics, antihistamines or costicosteroids.
The use of concomitant antitussive agents is not recommended.
In human studies, no interaction has been found between carbocisteine and antibiotics, antihistamines or costicosteroids.
Storage
Capsule: Store at temperatures not exceeding 30°C, away from direct sunlight.
Pediatric Syrup/Infant Drops: Store at temperatures not exceeding 25°C, away from direct sunlight.
Pediatric Syrup/Infant Drops: Store at temperatures not exceeding 25°C, away from direct sunlight.
MedsGo Class
Cough & Cold Preparations
Features
Brand
Loviscol
Full Details
Dosage Strength
100mg / 5ml
Drug Ingredients
- Carbocisteine
Drug Packaging
Syrup 120ml
Generic Name
Carbocisteine
Dosage Form
Syrup
Registration Number
DRHR-789
Drug Classification
Over-The-Counter (OTC)
Please sign in so that we can notify you about a reply